Articles published by Alvotech
Alvotech Issues New Shares to Holders of Convertible Bonds
Today 17:35 EDT
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024
Today 5:10 EDT
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe
June 18, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Strategic Refinancing Agreement
June 07, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
May 21, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Increase in Number of Own Shares
March 22, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
March 05, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Appoints Interim Chief Quality Officer
February 29, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
February 15, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
January 19, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
January 10, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
November 28, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Subscribe Now